NYUAD researchers unlock an epigenetic code that allows liver regeneration

NYU Abu Dhabi (NYUAD) researchers uncovered a code that sets the genome of the liver to account for the remarkable ability for this organ to regenerate. This finding offers new insight into how the specific genes that promote regeneration can be activated when part of the liver is removed. These findings have the potential to inform the development of a new form of regenerative medicine that could help non-regenerative organs regrow in mice and humans.

While other animals can regenerate most organs, humans, mice, and other mammals can only regenerate their liver in response to an injury or when a piece is removed. NYUAD researchers hypothesized that the genes that drive regeneration in the liver would be controlled by a specific code that allows them to be activated in response to injury or resection. They hone in on the epigenome, which is the modifications on the DNA that alter the gene expression, as opposed to changing the genetic code itself.

Using a mouse liver model, the team of NYUAD researchers, led by Professor of Biology Kirsten Sadler Edepli, identified the elements of the epigenetic code present in quiescent liver cells - cells that are currently not replicating but have the ability to proliferate under the right conditions - that activate specific genes to regenerate. Genes involved in liver cell proliferation are silenced in livers that are not regenerating, but the surprising finding was that they reside in parts of the genome where most genes are active. The researchers found that these pro-regenerative genes were marked with a specific modification - H3K27me3. During regeneration, H3K27me3 is depleted from these genes, enabling their dynamic expression and driving proliferation.

In the paper Chromatin states shaped by an epigenetic code confer regenerative potential to the mouse liver published in the journal Nature Communications, Sadler and the lead research scientist on her team, Chi Zhang, present the discovery that the mouse liver contains elements of the epigenetic code that allow pro-regenerative genes to activate when signaled. Epigenetic patterns are a well-established mechanism that coordinate gene expression. However, the way epigenetic patterns contribute to gene expression in the liver or how they impact liver regeneration was previously unknown. Their research uncovered six distinct chromatin states in the mouse liver corresponding to specific epigenetic marks, providing the first chromatin map of this important organ and showing that the elements of this map are essential for liver regeneration. This finding provides a mechanism that keeps cells in the liver in a "ready-set-go" state, in preparation for the signal to regenerate.

"The secret to regeneration is locked in a code in the liver epigenome. We are now studying the 'writers' of the epigenetic code -- the enzymes that create the epigenetic marks -- to see how this epigenetic code responds to aging, as the liver's ability to regenerate declines in older animals - including humans," said Sadler. "The continued study of the liver's remarkable ability to regenerate provides promise for the development of regenerative medicine; perhaps we can even try to write the code that allows regeneration in the young liver to cells in older animals, or even to tweak this code in other organs that don't regenerate and currently can only be replaced using complex, high-risk transplants."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New pipeline of drug candidates offers hope for effective MASLD treatments